Logo image of CXM

SPRINKLR INC-A (CXM) Stock Fundamental Analysis

NYSE:CXM - New York Stock Exchange, Inc. - US85208T1079 - Common Stock - Currency: USD

8.21  -0.19 (-2.26%)

Premarket: 8.4 +0.19 (+2.31%)

Fundamental Rating

5

Taking everything into account, CXM scores 5 out of 10 in our fundamental rating. CXM was compared to 282 industry peers in the Software industry. CXM has an average financial health and profitability rating. CXM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CXM had positive earnings in the past year.
CXM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CXM reported negative net income in multiple years.
Of the past 5 years CXM 4 years had a positive operating cash flow.
CXM Yearly Net Income VS EBIT VS OCF VS FCFCXM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

CXM has a Return On Assets of 9.20%. This is amongst the best in the industry. CXM outperforms 85.82% of its industry peers.
CXM's Return On Equity of 17.10% is amongst the best of the industry. CXM outperforms 84.40% of its industry peers.
With a decent Return On Invested Capital value of 4.36%, CXM is doing good in the industry, outperforming 74.11% of the companies in the same industry.
Industry RankSector Rank
ROA 9.2%
ROE 17.1%
ROIC 4.36%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
CXM Yearly ROA, ROE, ROICCXM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

CXM has a better Profit Margin (13.58%) than 80.85% of its industry peers.
CXM has a better Operating Margin (4.42%) than 71.28% of its industry peers.
CXM has a Gross Margin of 71.05%. This is comparable to the rest of the industry: CXM outperforms 57.80% of its industry peers.
CXM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.42%
PM (TTM) 13.58%
GM 71.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
CXM Yearly Profit, Operating, Gross MarginsCXM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CXM is destroying value.
Compared to 1 year ago, CXM has less shares outstanding
Compared to 5 years ago, CXM has more shares outstanding
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CXM Yearly Shares OutstandingCXM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXM Yearly Total Debt VS Total AssetsCXM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

CXM has an Altman-Z score of 2.72. This is not the best score and indicates that CXM is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.72, CXM perfoms like the industry average, outperforming 56.03% of the companies in the same industry.
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.72
ROIC/WACC0.49
WACC8.93%
CXM Yearly LT Debt VS Equity VS FCFCXM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.74 indicates that CXM should not have too much problems paying its short term obligations.
The Current ratio of CXM (1.74) is comparable to the rest of the industry.
A Quick Ratio of 1.74 indicates that CXM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.74, CXM perfoms like the industry average, outperforming 54.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
CXM Yearly Current Assets VS Current LiabilitesCXM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for CXM have decreased by -9.52% in the last year.
CXM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.75%.
The Revenue has been growing by 19.68% on average over the past years. This is quite good.
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%

3.2 Future

CXM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.36% yearly.
The Revenue is expected to grow by 8.62% on average over the next years. This is quite good.
EPS Next Y14.83%
EPS Next 2Y11.94%
EPS Next 3Y12.05%
EPS Next 5Y5.36%
Revenue Next Year3.92%
Revenue Next 2Y4.36%
Revenue Next 3Y5.45%
Revenue Next 5Y8.62%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CXM Yearly Revenue VS EstimatesCXM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CXM Yearly EPS VS EstimatesCXM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.61 indicates a rather expensive valuation of CXM.
CXM's Price/Earnings ratio is a bit cheaper when compared to the industry. CXM is cheaper than 77.31% of the companies in the same industry.
When comparing the Price/Earnings ratio of CXM to the average of the S&P500 Index (26.98), we can say CXM is valued inline with the index average.
The Price/Forward Earnings ratio is 18.72, which indicates a rather expensive current valuation of CXM.
Based on the Price/Forward Earnings ratio, CXM is valued a bit cheaper than 78.37% of the companies in the same industry.
CXM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 21.61
Fwd PE 18.72
CXM Price Earnings VS Forward Price EarningsCXM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

81.56% of the companies in the same industry are more expensive than CXM, based on the Enterprise Value to EBITDA ratio.
81.21% of the companies in the same industry are more expensive than CXM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.47
EV/EBITDA 20.18
CXM Per share dataCXM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CXM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CXM may justify a higher PE ratio.
A more expensive valuation may be justified as CXM's earnings are expected to grow with 12.05% in the coming years.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y11.94%
EPS Next 3Y12.05%

0

5. Dividend

5.1 Amount

No dividends for CXM!.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (6/27/2025, 8:04:00 PM)

Premarket: 8.4 +0.19 (+2.31%)

8.21

-0.19 (-2.26%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-04 2025-06-04/bmo
Earnings (Next)09-02 2025-09-02/amc
Inst Owners79.44%
Inst Owner Change-0.67%
Ins Owners6.03%
Ins Owner Change45.73%
Market Cap2.12B
Analysts65.56
Price Target9.89 (20.46%)
Short Float %7.16%
Short Ratio4.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.14%
Min EPS beat(2)21.24%
Max EPS beat(2)39.04%
EPS beat(4)3
Avg EPS beat(4)17.48%
Min EPS beat(4)-14.78%
Max EPS beat(4)39.04%
EPS beat(8)7
Avg EPS beat(8)34.7%
EPS beat(12)11
Avg EPS beat(12)104.49%
EPS beat(16)15
Avg EPS beat(16)86.72%
Revenue beat(2)1
Avg Revenue beat(2)0.39%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.8%
Revenue beat(4)3
Avg Revenue beat(4)0.58%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)1.16%
Revenue beat(8)6
Avg Revenue beat(8)1.02%
Revenue beat(12)9
Avg Revenue beat(12)0.95%
Revenue beat(16)13
Avg Revenue beat(16)1.74%
PT rev (1m)-5.75%
PT rev (3m)-8.71%
EPS NQ rev (1m)4.31%
EPS NQ rev (3m)4.31%
EPS NY rev (1m)4.11%
EPS NY rev (3m)3.9%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE 18.72
P/S 2.63
P/FCF 20.47
P/OCF 17.69
P/B 3.31
P/tB 3.59
EV/EBITDA 20.18
EPS(TTM)0.38
EY4.63%
EPS(NY)0.44
Fwd EY5.34%
FCF(TTM)0.4
FCFY4.89%
OCF(TTM)0.46
OCFY5.65%
SpS3.13
BVpS2.48
TBVpS2.29
PEG (NY)1.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.2%
ROE 17.1%
ROCE 5.13%
ROIC 4.36%
ROICexc 24.79%
ROICexgc 42.07%
OM 4.42%
PM (TTM) 13.58%
GM 71.05%
FCFM 12.83%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 86.2%
Cap/Sales 2.02%
Interest Coverage 250
Cash Conversion 219.67%
Profit Quality 94.52%
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 2.72
F-Score7
WACC8.93%
ROIC/WACC0.49
Cap/Depr(3y)122.21%
Cap/Depr(5y)126.89%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y14.83%
EPS Next 2Y11.94%
EPS Next 3Y12.05%
EPS Next 5Y5.36%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%
Revenue Next Year3.92%
Revenue Next 2Y4.36%
Revenue Next 3Y5.45%
Revenue Next 5Y8.62%
EBIT growth 1Y-16.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.65%
EBIT Next 3Y38.13%
EBIT Next 5Y27.49%
FCF growth 1Y241.27%
FCF growth 3YN/A
FCF growth 5Y33.79%
OCF growth 1Y148.61%
OCF growth 3YN/A
OCF growth 5Y32.54%